Harmony Biosciences
HRMY
HRMY
216 hedge funds and large institutions have $1.68B invested in Harmony Biosciences in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 79 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
40% less capital invested
Capital invested by funds: $2.78B → $1.68B (-$1.1B)
40% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 52
52% less call options, than puts
Call options by funds: $4.05M | Put options by funds: $8.4M
Holders
216
Holding in Top 10
5
Calls
$4.05M
Puts
$8.4M
Top Buyers
| 1 | +$42M | |
| 2 | +$15.3M | |
| 3 | +$12.9M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$9.99M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.16M |
Top Sellers
| 1 | -$40.5M | |
| 2 | -$29.4M | |
| 3 | -$23.6M | |
| 4 |
Man Group
London,
United Kingdom
|
-$13.1M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$10.7M |